Cargando…

Molecular Pathogenesis and Targeted Therapies in Well-Differentiated Thyroid Carcinoma

Four proto-oncogenes commonly associated with well-differentiated thyroid carcinoma, rearranged during transfection (RET)/papillary thyroid cancer, BRAF, RAS, and PAX8/peroxisome proliferator activated receptor-γ, may carry diagnostic and prognostic significance. These oncogenes can be used to impro...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kim, Jung Guk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192816/ https://www.ncbi.nlm.nih.gov/pubmed/25309777 http://dx.doi.org/10.3803/EnM.2014.29.3.211

Ejemplares similares

Molecular pathogenesis of pediatric thyroid carcinoma
por: Mitsutake, Norisato, et al.
Publicado: (2021)

Thyroid eye disease: From pathogenesis to targeted therapies
por: Yoon, Jin Sook, et al.
Publicado: (2022)

Mutation Profile of Well-Differentiated Thyroid Cancer in Asians
por: Song, Young Shin, et al.
Publicado: (2015)

Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †
por: Cavalheiro, Beatriz G., et al.
Publicado: (2023)

Radiofrequency Ablation to Treat Loco-Regional Recurrence of Well-Differentiated Thyroid Carcinoma
por: Lee, Sun Jin, et al.
Publicado: (2014)

Basal Cell Carcinoma: From the Molecular Understanding of the Pathogenesis to Targeted Therapy of Progressive Disease
por: Göppner, Daniela, et al.
Publicado: (2011)

Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers
por: Mady, Leila J., et al.
Publicado: (2020)

Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates
por: Choi, Hye Ryeon, et al.
Publicado: (2023)

Robot-Assisted Thyroidectomy Versus Open Thyroidectomy in the Treatment of Well Differentiated Thyroid Carcinoma
por: Pavlidis, Efstathios T., et al.
Publicado: (2021)

Advances in Molecular Profiling and Their Potential Influence on the Extent of Surgery in Well-Differentiated Thyroid Carcinoma (WDTC)
por: Parpounas, Constantinos, et al.
Publicado: (2023)

Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma
por: Xie, Caiqin, et al.
Publicado: (2020)

Well-Differentiated Thyroid Carcinomas: Management of the Central Lymph Node Compartment and Emerging Biochemical Markers
por: Yeung, Meei J., et al.
Publicado: (2011)

Anaplastic carcinoma following well-differentiated thyroid cancer: etiological considerations.
por: Kapp, D. S., et al.
Publicado: (1982)

Prognostic Factors in Patients with Multiple Recurrences of Well-Differentiated Thyroid Carcinoma
por: Holler, Theresa, et al.
Publicado: (2009)

New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer
por: Antonelli, Alessandro, et al.
Publicado: (2010)

Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management
por: Yuan, Jiaqian, et al.
Publicado: (2022)

Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the Paradigm
por: Goldsmith, Stanley J.
Publicado: (2017)

Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
por: Chung, June-Key, et al.
Publicado: (2014)

New Molecular Targeted Therapy and Redifferentiation Therapy for Radioiodine-Refractory Advanced Papillary Thyroid Carcinoma: Literature Review
por: Wong, Kai-Pun, et al.
Publicado: (2012)

Surgical Management of Tracheal Invasion by Well-Differentiated Thyroid Cancer
por: Matsumoto, Fumihiko, et al.
Publicado: (2021)

Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
por: Llovet, Josep M., et al.
Publicado: (2022)

Medullary Thyroid Carcinoma: Targeted Therapies and Future Directions
por: Pinchot, Scott N., et al.
Publicado: (2009)

The role of Notch signaling in gastric carcinoma: molecular pathogenesis and novel therapeutic targets
por: Yao, Yizheng, et al.
Publicado: (2017)

Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Tracheal Obstruction by an Invading Well-Differentiated Thyroid Carcinoma
por: Pontikides, Nickolaos, et al.
Publicado: (2013)

Molecular Aspects of COVID-19 Differential Pathogenesis
por: Rothan, Hussin A., et al.
Publicado: (2020)

Recent advances in the understanding of the molecular pathogenesis and targeted therapy options in Langerhans cell histiocytosis
por: Suh, Jin Kyung, et al.
Publicado: (2021)

Medullary Thyroid Carcinoma: Molecular Signaling Pathways and Emerging Therapies
por: Gómez, Karen, et al.
Publicado: (2011)

The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
por: Van Roy, Nadine, et al.
Publicado: (2009)

Etiopathogenesis of Differentiated Thyroid Carcinomas
por: Makazlieva, Tanja, et al.
Publicado: (2016)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

Alveolar Soft Part Sarcomas: Molecular Pathogenesis and Implications for Novel Targeted Therapies
por: Mitton, Bryan, et al.
Publicado: (2012)

Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies
por: Harada, Hironori, et al.
Publicado: (2015)

Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
por: Cucarull, Blanca, et al.
Publicado: (2022)

An update on the pathogenesis of Hashimoto’s thyroiditis
por: Weetman, A. P.
Publicado: (2020)

Immunocytochemistry Test of Protein BRAF Expression for Diagnosis of Well Differentiated Thyroid Carcinoma
por: Sudarsa, I. Wayan, et al.
Publicado: (2018)

Thyroid Carcinoma Coexisting with Hashimoto’s Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis
por: Molnár, Csaba, et al.
Publicado: (2019)

Psoriatic Arthritis: Pathogenesis and Targeted Therapies
por: Azuaga, Ana Belén, et al.
Publicado: (2023)

The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies
por: Liu, Jiahua, et al.
Publicado: (2023)

The Molecular Pathogenesis and Clinical Implications of Hepatocellular Carcinoma
por: Meguro, Makoto, et al.
Publicado: (2011)

Study of Serum Leptin in Well-differentiated Thyroid Carcinoma: Correlation with Patient and Tumor Characteristics
por: Rehem, Rania Abdel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_utm8jmbbvcfa0aveub8fheju3h